111 related articles for article (PubMed ID: 14561086)
21. Inhibitors of unactivated p38 MAP kinase.
Bullington J; Argentieri D; Averill K; Carter D; Cavender D; Fahmy B; Fan X; Hall D; Heintzelman G; Jackson P; Leung WP; Li X; Ling P; Olini G; Razler T; Reuman M; Rupert K; Russell R; Siekierka J; Wadsworth S; Wolff R; Xiang B; Zhang YM
Bioorg Med Chem Lett; 2006 Dec; 16(23):6102-6. PubMed ID: 16971122
[TBL] [Abstract][Full Text] [Related]
22. Dissection of the recognition properties of p38 MAP kinase. Determination of the binding mode of a new pyridinyl-heterocycle inhibitor family.
Soliva R; Gelpí JL; Almansa C; Virgili M; Orozco M
J Med Chem; 2007 Jan; 50(2):283-93. PubMed ID: 17228870
[TBL] [Abstract][Full Text] [Related]
23. Ligand binding affinity determined by temperature-dependent circular dichroism: cyclin-dependent kinase 2 inhibitors.
Mayhood TW; Windsor WT
Anal Biochem; 2005 Oct; 345(2):187-97. PubMed ID: 16140252
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and biophysical characterization of unique switch pocket inhibitors of p38α.
Swann SL; Merta PJ; Kifle L; Groebe D; Sarris K; Hajduk PJ; Sun C
Bioorg Med Chem Lett; 2010 Oct; 20(19):5787-92. PubMed ID: 20471255
[TBL] [Abstract][Full Text] [Related]
25. General model for estimation of the inhibition of protein kinases using Monte Carlo simulations.
Tominaga Y; Jorgensen WL
J Med Chem; 2004 May; 47(10):2534-49. PubMed ID: 15115396
[TBL] [Abstract][Full Text] [Related]
26. The molecular basis for coxib inhibition of p38alpha MAP kinase.
Sperandio da Silva GM; Lima LM; Fraga CA; Sant'Anna CM; Barreiro EJ
Bioorg Med Chem Lett; 2005 Aug; 15(15):3506-9. PubMed ID: 15990304
[TBL] [Abstract][Full Text] [Related]
27. Effect of construct design on MAPKAP kinase-2 activity, thermodynamic stability and ligand-binding affinity.
Kervinen J; Ma H; Bayoumy S; Schubert C; Milligan C; Lewandowski F; Moriarty K; Desjarlais RL; Ramachandren K; Wang H; Harris CA; Grasberger B; Todd M; Springer BA; Deckman I
Arch Biochem Biophys; 2006 May; 449(1-2):47-56. PubMed ID: 16620770
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor.
Matulis D; Kranz JK; Salemme FR; Todd MJ
Biochemistry; 2005 Apr; 44(13):5258-66. PubMed ID: 15794662
[TBL] [Abstract][Full Text] [Related]
29. The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitors.
Montalban AG; Boman E; Chang CD; Ceide SC; Dahl R; Dalesandro D; Delaet NG; Erb E; Ernst JT; Gibbs A; Kahl J; Kessler L; Lundström J; Miller S; Nakanishi H; Roberts E; Saiah E; Sullivan R; Wang Z; Larson CJ
Bioorg Med Chem Lett; 2008 Mar; 18(6):1772-7. PubMed ID: 18325768
[TBL] [Abstract][Full Text] [Related]
30. Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase.
Hammach A; Barbosa A; Gaenzler FC; Fadra T; Goldberg D; Hao MH; Kroe RR; Liu P; Qian KC; Ralph M; Sarko C; Soleymanzadeh F; Moss N
Bioorg Med Chem Lett; 2006 Dec; 16(24):6316-20. PubMed ID: 17010605
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors.
Wrobleski ST; Lin S; Hynes J; Wu H; Pitt S; Shen DR; Zhang R; Gillooly KM; Shuster DJ; McIntyre KW; Doweyko AM; Kish KF; Tredup JA; Duke GJ; Sack JS; McKinnon M; Dodd J; Barrish JC; Schieven GL; Leftheris K
Bioorg Med Chem Lett; 2008 Apr; 18(8):2739-44. PubMed ID: 18364256
[TBL] [Abstract][Full Text] [Related]
32. Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics.
Kolobe D; Sayed Y; Dirr HW
Biochem J; 2004 Sep; 382(Pt 2):703-9. PubMed ID: 15147239
[TBL] [Abstract][Full Text] [Related]
33. Part 1: Structure-Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Wurz RP; Pettus LH; Xu S; Henkle B; Sherman L; Plant M; Miner K; McBride H; Wong LM; Saris CJ; Lee MR; Chmait S; Mohr C; Hsieh F; Tasker AS
Bioorg Med Chem Lett; 2009 Aug; 19(16):4724-8. PubMed ID: 19574047
[TBL] [Abstract][Full Text] [Related]
34. Enhanced selectivity profile of pyrazole-urea based DFG-out p38alpha inhibitors.
Liu H; Kuhn C; Feru F; Jacques SL; Deshmukh GD; Ye P; Rennie GR; Johnson T; Kazmirski S; Low S; Coli R; Ding YH; Cheng AC; Tecle H; English JM; Stanton R; Wu JC
Bioorg Med Chem Lett; 2010 Aug; 20(16):4885-91. PubMed ID: 20620059
[TBL] [Abstract][Full Text] [Related]
35. Time-resolved Forster resonance energy transfer assays for the binding of nucleotide and protein substrates to p38alpha protein kinase.
Zhang WX; Wang R; Wisniewski D; Marcy AI; LoGrasso P; Lisnock JM; Cummings RT; Thompson JE
Anal Biochem; 2005 Aug; 343(1):76-83. PubMed ID: 15979553
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1.
Tynebor RM; Chen MH; Natarajan SR; O'Neill EA; Thompson JE; Fitzgerald CE; O'Keefe SJ; Doherty JB
Bioorg Med Chem Lett; 2011 Jan; 21(1):411-6. PubMed ID: 21084192
[TBL] [Abstract][Full Text] [Related]
37. New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP site.
Moss N; Breitfelder S; Betageri R; Cirillo PF; Fadra T; Hickey ER; Kirrane T; Kroe RR; Madwed J; Nelson RM; Pargellis CA; Qian KC; Regan J; Swinamer A; Torcellini C
Bioorg Med Chem Lett; 2007 Aug; 17(15):4242-7. PubMed ID: 17560108
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase.
Cogan DA; Aungst R; Breinlinger EC; Fadra T; Goldberg DR; Hao MH; Kroe R; Moss N; Pargellis C; Qian KC; Swinamer AD
Bioorg Med Chem Lett; 2008 Jun; 18(11):3251-5. PubMed ID: 18462940
[TBL] [Abstract][Full Text] [Related]
39. Discovering new MAP kinase inhibitors.
Shapiro P
Chem Biol; 2006 Aug; 13(8):807-9. PubMed ID: 16931329
[TBL] [Abstract][Full Text] [Related]
40. 5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38alpha MAP kinase.
Liu C; Wrobleski ST; Lin J; Ahmed G; Metzger A; Wityak J; Gillooly KM; Shuster DJ; McIntyre KW; Pitt S; Shen DR; Zhang RF; Zhang H; Doweyko AM; Diller D; Henderson I; Barrish JC; Dodd JH; Schieven GL; Leftheris K
J Med Chem; 2005 Oct; 48(20):6261-70. PubMed ID: 16190753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
